CollimateHealth Raises €6 Million in Seed Round
CollimateHealth, a Munich-based healthtech startup, has raised €6 million in a seed funding round dated June 15, 2026. The funding was led by High-Tech Gründerfonds (HTGF) and included investments from Positron, XISTA Science Ventures, and caesar. The company is focused on developing advanced cancer treatment technology that aims to significantly reduce the size of traditional radiation therapy equipment.
Innovating Cancer Treatment
Founded by Hans Maria Heÿn (CEO), Johanna Winter (CTO), and Stefan Bartzsch (CSO), CollimateHealth is working on a groundbreaking approach to microbeam radiation therapy. The company's technology is designed to shrink the footprint of conventional cancer treatment machines from the size of a football stadium to just 10 square meters, making it more accessible and cost-effective for healthcare providers.
Strategic Investment by Leading VCs
The lead investor, HTGF, is a prominent venture capital firm known for its focus on innovative startups in the tech and science sectors. Their involvement in CollimateHealth's seed round underscores the potential impact of the startup's technology on the healthcare industry.
Plans for the New Funding
The newly secured funds will be directed towards further developing CollimateHealth's technology and scaling its operations. This includes advancing research and development efforts, as well as expanding the company's team to accelerate the technology's journey from concept to market-ready product. "We are excited to have the support of such experienced investors as we work towards revolutionizing cancer treatment," said Hans Maria Heÿn, CEO of CollimateHealth.
Expanding the Team and Technology
In addition to enhancing its technology, CollimateHealth plans to use part of the funding to hire additional experts in the field of radiation therapy and medical technology. This will enable the company to strengthen its capabilities and push forward the development of its innovative solutions.
Looking Ahead
As CollimateHealth continues to develop its technology, the company aims to make significant strides in the field of cancer treatment. By reducing the size and cost of radiation therapy equipment, they hope to make advanced cancer treatment more accessible to hospitals and clinics worldwide. With the backing of prominent investors and a clear vision for the future, CollimateHealth is positioned to make a significant impact on the healthcare industry.